Canada Cataract Surgery Devices Market Overview,2030

Canada’s cataract surgery devices market has evolved over decades into one of the most advanced ophthalmic sectors in North America, shaped by the country’s commitment to healthcare innovation and accessibility. Historically, cataract treatment in Canada was limited to basic surgical procedures that restored vision but often required thick corrective lenses afterward. The introduction of intraocular lenses (IOLs) in the 1970s marked a revolutionary shift, and by the 1990s, Canadian hospitals had widely adopted phacoemulsification, a minimally invasive ultrasound-based technique that made cataract surgery faster, safer, and more precise. This early adoption placed Canada at the forefront of global ophthalmic care. With nearly one in five Canadians projected to be over the age of 65 within the next decade, cataract prevalence has increased dramatically, making the procedure one of the most commonly performed surgeries in the country. Patients are increasingly opting for advanced surgical options that not only remove cataracts but also correct refractive errors such as astigmatism and presbyopia. This has led to greater demand for next-generation IOLs, including multifocal, toric, and extended-depth-of-focus lenses that offer improved vision quality and reduce dependence on glasses. Moreover, Health Canada’s strict regulatory framework ensures that all cataract surgery devices undergo rigorous safety and efficacy testing before being introduced into the market. These regulations align with international standards, maintaining high levels of patient safety while fostering trust in Canadian medical practices.

According to the research report "" Canada Cataract Surgery Devices Market Overview, 2030,"" published by Bonafide Research, the Canada Cataract Surgery Devices market is expected to reach a market size of USD 360 Million by 2030. The market has witnessed several technological advancements tailored to the specific needs of Canadian healthcare facilities, including ergonomic phacoemulsification consoles, portable diagnostic units, and digital surgical planning tools. As teleophthalmology and AI-based diagnostics expand, integration with cataract surgical systems is improving preoperative assessments and post-operative outcomes. Additionally, many provinces have initiated policies to reduce surgical wait times by expanding the role of outpatient surgical centers, further boosting the demand for efficient and cost-effective cataract devices. The regulatory and policy environment in Canada characterized by rigorous device licensing and provincial funding models that cover standard cataract extraction but often exclude premium implants and certain advanced interventions creates a two-tier market dynamic: universal access to basic sight-restoring care alongside a growing private-pay segment for premium optics and elective enhancements. This dual structure generates clear opportunities for manufacturers and service providers to offer tiered product portfolios, financing and training to lower barriers to adoption. Practical opportunities and recent developments in Canada include expansion of ambulatory surgical centres and specialized cataract hubs that centralize high-volume lists; partnerships between device companies and health systems to deliver bundled offerings (equipment, disposables, software and training); and the rollout of teleophthalmology and remote monitoring for pre-op screening and post-op follow-up, which reduce clinic burden and improve patient throughput.

Intraocular lenses (IOLs) represent the largest share of the Canadian market, as cataract surgery remains one of the most commonly performed procedures in the nation’s public health system. The demand for premium IOLs, such as multifocal and toric lenses, is rising, though adoption is slower than in the U.S. due to partial or limited reimbursement under provincial health insurance plans, which mainly cover standard monofocal lenses. Nevertheless, Canada’s aging population and patient willingness to pay out-of-pocket for superior vision correction are driving gradual growth in this category. Phacoemulsification systems are widely used across hospitals and ambulatory surgical centers, with Canadian surgeons relying on advanced equipment from global manufacturers like Alcon, Bausch + Lomb, and Johnson & Johnson Vision to ensure safe, precise, and quick cataract removal. Ophthalmic viscoelastic devices (OVDs), essential for intraoperative tissue protection, continue to see steady demand as Canadian facilities emphasize minimally invasive techniques and improved patient comfort. The adoption of femtosecond laser systems is increasing, particularly in private or hybrid clinics that cater to patients seeking premium, bladeless cataract surgery, despite the higher upfront equipment cost. The other devices category including surgical blades, forceps, and disposable tools-supports the country’s widespread surgical programs, ensuring accessibility and cost control, especially in remote regions where affordability and supply logistics are key factors.

Hospitals remain the cornerstone of cataract surgeries across Canada, largely due to the robust public healthcare infrastructure managed by provincial health authorities such as Ontario Health, Alberta Health Services, and the British Columbia Ministry of Health. These institutions handle a majority of cataract procedures under publicly funded programs, ensuring universal access to surgical eye care regardless of income or geographic location. Equipped with cutting-edge phacoemulsification systems, ophthalmic viscoelastic devices, and advanced intraocular lenses, Canadian hospitals emphasize precision, safety, and efficiency in managing large surgical volumes. In major urban centers like Toronto, Calgary, and Vancouver, tertiary hospitals also serve as referral hubs for complex cases and training sites for ophthalmology residents. However, a clear structural shift is underway toward ambulatory surgery centers (ASCs) and independent health facilities (IHFs), reflecting Canada’s broader health system modernization goals. These centers are gaining momentum as the government actively seeks to reduce surgical backlogs and wait times for elective procedures through outpatient service expansion. Ophthalmology clinics complement these institutional settings by providing essential diagnostic, pre-operative assessment, and post-surgical follow-up care. Academic and research institutions further strengthen the national cataract surgery ecosystem through innovation, training, and collaborative research. Universities like Toronto, McGill, and the University of British Columbia run ophthalmology residency and fellowship programs that train surgeons in both traditional and next-generation techniques, including robotic-assisted cataract procedures and AI-guided diagnostics.

Considered in this report
• Historic Year: 2019
• Base year: 2024
• Estimated year: 2025
• Forecast year: 2030

Aspects covered in this report
• Cataract Surgery Devices Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type
• Intra-ocular Lenses (IOL)
• Phacoemulsification Systems
• Ophthalmic Viscoelastic Devices
• Femtosecond Laser Systems
• Others (Knives and Low-Cost Consumables)

By End User
• Hospitals
• Ambulatory Surgery Centers
• Ophthalmology Clinics
• Academic and Research Institutes Show more